Sarepta Therapeutics
SRPT · NASDAQ
Bulios Fair Price
$28.34
40.8% upside
Trenutna cena
$20.12
Po podatkih Bulios Fair Price je delnica SRPT trenutno podcenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
O podjetju
Sarepta Therapeutics, Inc. (SRPT) is an American biopharmaceutical company focused on research, development, and commercialization of drugs for the treatment of rare genetic diseases. The company specializes in treating muscular dystrophies caused by genetic mutations. Sarepta Therapeutics develops innovative therapies based on gene therapy and RNA technologies, which have the potential to provide new treatment options for patients with rare genetic diseases. With its successful research programs and collaboration with renowned experts in the field, the company has become a significant player in the field of muscular dystrophy treatment. Shares of Sarepta Therapeutics, Inc. (SRPT) can represent an interesting investment opportunity for those seeking exposure to the biotechnology industry with a focus on treating rare genetic diseases and innovative therapeutic approaches.
V vašem jeziku še ni na voljo, zato je besedilo v angleščini.
Sector
Healthcare
Industry
Biotechnology
CEO
Michael E. Severino
Employees
835
Headquarters
Cambridge
Prihajajoči dogodki
Earnings
Upcoming earnings report